[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335210-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335210-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","relapse-and-survival-in-bladder-cancer-patients-undergoing-microrna-129-and-microrna-145-assays","Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays","","Objective: The lack of reliable indicators for the tumor’s invasive biological behavior motivates this study. The aim was to evaluate how microRNA (miRNA) 129 and miRNA 145 relate to tumor progression and patient survival. Method: Seventy-five bladder cancer patients and 75 controls were enrolled, with miRNA levels quantified by real-time PCR. ROC curves and AUC assessed diagnostic performance, and survival associations were analyzed using Kaplan–Meier and Cox regression. Conclusion: The miRNA signature supports detection of survival-associated markers and informs miRNA therapeutic development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/relapse-and-survival-in-bladder-cancer-patients-undergoing-microrna-129-and-microrna-145-assays/335210/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/relapse-and-survival-in-bladder-cancer-patients-undergoing-microrna-129-and-microrna-145-assays/335210.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To examine the effects of microRNA-129 and microRNA-145 on tumor progression and patient survival in bladder cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were microRNA-129 and microRNA-145 levels measured?",{"text":68,"@type":64},"Total RNA containing miRNA was extracted from samples and quantified using RT-qPCR with real-time PCR reaction conditions and designed primers.",{"name":70,"@type":61,"acceptedAnswer":71},"Which microRNAs showed diagnostic value and what were the key findings?",{"text":72,"@type":64},"Both miR-129 and miR-145 were significant, with classifiers using AUC values of 0.943 for miR-129 and 0.748 for miR-145, supporting diagnostic potential.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335210,1790814984,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","RESEARCH ARTICLE  \nEditorial Process: Submission:02/01/2024 Acceptance:06/17/2024  \nRelapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays  \nMostafa MM ELfieky1, Mohamed AbdEl Rahman2,3*, Aysam M Fayed1,4, Zahraa Haleem Al-Qaim5, Ahmed Khalid Aldhalmi2, EmanAE Badr6, AmalAbdel Aziz1, Gehan MA Ibrahim1  \nAbstract  \nObjective: The lack of indicators to measure tumor’s invasive biological behavior is an important issue. The aim of this study was to examine the effect of miRNAs 129 and 145 on tumor progression as well as patient survival. Method: Seventy five breast cancer (BC) patients and 75 controls were included in this research. Two miRNA expressions were estimated using real-time PCR. Biomarkers for BC detection was tested using ROC curves andAUC. Result: miR-129 and miR-145 expressions were significant. miR-129 and miR-145 classifiers (AUC = 0.943 and 0.748, respectively) help diagnose BC. Unlike miR-145, miR-129 did not affect the Kaplan–Meier survival curve analysis for progressionfree survival at the end of the trial. The development of transitional cell carcinoma disease was found to have a strong correlation with miR-145 in both univariate and multivariate Cox regression analyses. Additionally, infiltrating + invasive urothelial carcinoma was also found to be correlated with miR-145. Conversely, elevated miR-129 expression in BC patients did not lead to an increase in cancer-specific recurrence or mortality, as observed in both univariate and multivariate Cox regression studies. Conclusion: The miRNA signature can help detect survival-associated miRNAsand develop BC miRNA therapeutics.  \nKeywords: Bladder cancer-microRNA 129-microRNA 145-relapse-survival  \nAsian Pac J Cancer Prev, 25 (6), 2113-2121  \nIntroduction  \nBladder cancer (BC) ranks 7th and 14th in men and women worldwide, respectively [1] . In industrialized countries, men develop BC. It remains the most frequent urinary cancer [2] . Most BCs (stages Ta and T1) are nonmuscle invasive and successful. T2–T4 muscleinvasive bladder tumors are distantly invasive [3,4] . BC is primarily hereditary and environmental [5] . Despite advancements in surgery, radiation, and chemotherapy, breast cancer remains highly fatal [6] . Established BC biomarkers have many diagnostic limitations [7-10] . Novel markers are required to identify and predict BC atan early stage.  \nPosttranscriptionally, microRNAs (miRNAs) influence gene expression and become tumor suppressors oroncogenes [11,12] . BC miRNA dysregulation was associated with BC [13-15] . Thus, miRNAs can detect cancer. Prior studies demonstrated that miRNAs alter BC  \ncell motility, invasion, proliferation, and survival.  \nSeveral studies reported miR-129-5p to be the most downregulated in spinal tissues . miR-129-5poverexpression improved spinal tissue inflammation, apoptosis, and functional recovery in injured animals [16,17] . Tumor growth and progression involve miR- 145-5p. Few studies explored BC and miR-145-5p. miR- 145-5p was found in BC cell proliferation and migration [18,19] . The aim of this study was to examine the effect of miRNAs 129 and 145 on tumor progression as well as patient survival.  \nMaterials and Methods  \nIn this study, 150 participants were included: 75 with BC and 75 healthy volunteers confirmed using cystoscopy. This research was conducted at the Clinical Urology Department, Faculty of Medicine, Menoufia University, from November 2021 to December 2022.  \n1Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt. 2College of Pharmacy, Al-Mustaqbal University, Babylon, 51001, Iraq. 3Clinical Pharmacy Department, Badr University Hospital, Faculty of Medicine, Helwan University, Egypt. 4Medical Laboratory Techniques Department, College of Health and Medical Technique, Al-Mustaqbal University, Babylon,51001, Iraq. 5Department of Anesthesia Techniques, Al-Mustaqbal University College, Ira","cbCaib5miOHrwBFD","https://ap.wps.com/l/cbCaib5miOHrwBFD","pdf",512633,"English","# Abstract\n# Introduction\n# Materials and Methods","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To examine the effects of microRNA-129 and microRNA-145 on tumor progression and patient survival in bladder cancer patients.\"},{\"question\":\"How were microRNA-129 and microRNA-145 levels measured?\",\"answer\":\"Total RNA containing miRNA was extracted from samples and quantified using RT-qPCR with real-time PCR reaction conditions and designed primers.\"},{\"question\":\"Which microRNAs showed diagnostic value and what were the key findings?\",\"answer\":\"Both miR-129 and miR-145 were significant, with classifiers using AUC values of 0.943 for miR-129 and 0.748 for miR-145, supporting diagnostic potential.\"}]","Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays | PDF",1790010167,23]